Medical Meetings

Learn about the latest myeloma research. Get a front row seat at the most critical medical meetings. Watch Dr. Brian Durie, IMF Chairman, address issues that are important to the entire myeloma community. IMF TV brings it all to you.

Jun
04
Value and Cost of Multiple Myeloma Therapy
Dr. Vincent Rajkumar, Mayo Clinic, talks about the value and cost of mulitple myeloma therapy.
Jun
04
Le myélome multiple ASCO 2018 faits saillants
Dr. Philippe Moreau talks about the ongoing clinical trials in multiple myeloma, frontline therapies for young and elderly patients, and the future of CAR-T cell therapy.
Jun
04
Daratumumab in combination with carfilzomib and dexamethasone in lenalidomide-refractory patients with relapsed multiple myeloma
In this video, Dr. Ajai Chari (Icahn School of Medicine, Mt. Sinai Hospital, New York) discusses an update of a phase III study that looks at safety and efficacy of the combination of daratumumab +(...)
Jun
04
Phase II study of ex vivo expanded cord blood natural killer cells for multiple myeloma
In this video, Dr. Nina Shah (University of California at San Francisco) presents the results of a phase II study that uses natural killer (NK) cells that were derived from umbilical cord blood to(...)
Jun
03
Practical Considerations for Monoclonal Antibodies in Multiple Myeloma
Dr. Joseph Mikhael talks about the practical considerations for monoclonal antibodies in multiple myeloma.
Jun
03
Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with RR multiple myeloma
Dr. Luciano Costa talks about the triplet of venetoclax, carfilzomib, and dexamethasone in patients with relapsed/refractory multiple myeloma.